EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+1.73%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$8.15B
AUM Growth
-$196M
(-2.4%)
Cap. Flow
+$63.3M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
27.57%
Holding
907
New
39
Increased
187
Reduced
142
Closed
42
Top Buys
| 1 |
Dollar General
DG
|
$49.2M |
| 2 |
Abbott
ABT
|
$48.4M |
| 3 |
HES
Hess
HES
|
$47.1M |
| 4 |
Progressive
PGR
|
$40M |
| 5 |
Microsoft
MSFT
|
$31.2M |
Top Sells
| 1 |
Netflix
NFLX
|
$71.8M |
| 2 |
PACCAR
PCAR
|
$61.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$40.6M |
| 4 |
Biogen
BIIB
|
$34.5M |
| 5 |
Broadcom
AVGO
|
$29M |
Sector Composition
| 1 | Technology | 36.17% |
| 2 | Healthcare | 14.32% |
| 3 | Financials | 13.21% |
| 4 | Communication Services | 10.05% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
EQT Corp
EQT
$32.2B
| $842K | 0.01% |
+19,000
| New | +$842K |
|
402
Elevance Health
ELV
$70.6B
| $837K | 0.01% |
2,258
+390
| +21% | +$145K |
|
403
MoonLake Immunotherapeutics
MLTX
$3.77B
| $831K | 0.01% |
15,000
| – | – |
|
404
DexCom
DXCM
$31.6B
| $827K | 0.01% |
10,308
| – | – |
|
405
CSX Corp
CSX
$60.6B
| $779K | 0.01% |
24,001
-39,838
| -62% | -$1.29M |
|
406
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $769K | 0.01% |
448,618
-202,400
| -31% | -$347K |
|
407
Afya
AFYA
$1.37B
| $764K | 0.01% |
48,191
| – | – |
|
408
Archrock
AROC
$4.44B
| $761K | 0.01% |
31,000
| – | – |
|
409
Estee Lauder
EL
$32.1B
| $756K | 0.01% |
10,136
| – | – |
|
410
Sociedad Química y Minera de Chile
SQM
$13.1B
| $747K | 0.01% |
20,000
| – | – |
|
411
Corteva
CTVA
$49.1B
| $744K | 0.01% |
13,000
-800
| -6% | -$45.8K |
|
412
CVS Health
CVS
$93.6B
| $743K | 0.01% |
16,692
-82,829
| -83% | -$3.69M |
|
413
Veracyte
VCYT
$2.55B
| $682K | 0.01% |
17,000
| – | – |
|
|
TPIC
414
DELISTED
TPI Composites
TPIC
| $659K | 0.01% |
346,092
-1,402,133
| -80% | -$2.67M |
|
415
Day One Biopharmaceuticals
DAWN
$773M
| $659K | 0.01% |
51,200
| – | – |
|
416
Texas Pacific Land
TPL
$20.4B
| $653K | 0.01% |
570
+190
| +50% | +$218K |
|
417
Ultragenyx Pharmaceutical
RARE
$3.07B
| $652K | 0.01% |
15,010
| – | – |
|
418
Unum
UNM
$12.6B
| $651K | 0.01% |
8,900
+100
| +1% | +$7.32K |
|
419
NNN REIT
NNN
$8.18B
| $648K | 0.01% |
16,000
+3,200
| +25% | +$130K |
|
420
Blue Owl Capital
OWL
$11.6B
| $616K | 0.01% |
26,350
| – | – |
|
421
Freshpet
FRPT
$2.7B
| $616K | 0.01% |
4,210
| – | – |
|
422
Alamos Gold
AGI
$13.5B
| $601K | 0.01% |
32,700
| – | – |
|
423
Progyny
PGNY
$1.94B
| $600K | 0.01% |
35,528
| – | – |
|
424
Chemours
CC
$2.34B
| $598K | 0.01% |
35,142
| – | – |
|
425
GFL Environmental
GFL
$17.4B
| $597K | 0.01% |
13,371
+261
| +2% | +$11.7K |
|